Essity B stock gains as Edgewell feminine care acquisition closes

Published on 09/18/2026 at 10:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Essity B stock is in focus after Edgewell Personal Care completed the sale of its Feminine Care segment to Essity for about USD 340 million on September 17, 2026. The shares closed at SEK 264.30 on Nasdaq Stockholm on September 17, 2026, modestly below their 52-week high.

Essity AB SE0009922164: Fabrikhalle mit Hygienepapierrollen und Personal — Essity AB (ISIN SE0009922164) betreibt moderne Fabriken zur Herstellung von Hygiene- und Papierprodukten weltweit heute, Illustration mit AI erstellt.

Essity AB (publ) B stock (ISIN SE0009922164) drew fresh investor attention as of September 17, 2026 after Edgewell Personal Care completed the sale of its Feminine Care segment to Essity for about USD 340 million in cash, reshaping the hygiene group’s product portfolio. As of the latest completed trading day on Nasdaq Stockholm, Essity B closed at SEK 264.30 on September 17, 2026, reflecting a modest daily gain and positioning the shares close to their recent 52-week trading range.

Edgewell feminine care deal reshapes Essity’s portfolio

According to Ad-hoc-news on September 17, 2026, Edgewell Personal Care has closed the sale of its Feminine Care segment, including brands such as Playtex, Stayfree, Carefree and o.b., to Essity for approximately USD 340 million on a cash-free, debt-free basis.

As Ad-hoc-news reports, the sale was completed after the end of Edgewell’s fiscal second quarter 2026, meaning Essity will consolidate the acquired brands from the second half of 2026 onward.

The roughly USD 340 million purchase price expands Essity’s presence in branded feminine hygiene products in North America and other markets, complementing its existing tissue and personal care portfolio. For investors, the size of the transaction is notable because it represents a meaningful bolt-on acquisition relative to Essity’s prior-year earnings base.

Recent trading levels and valuation context

Price data from Nasdaq Stockholm compiled by Yahoo Finance show Essity B closing at SEK 264.30 on September 17, 2026, up 0.23 percent on the day, with the last trade recorded at 5:29 p.m. Central European time.

According to the same Yahoo Finance data, Essity B’s recent 52-week high is in the low SEK 270s and the 52-week low is in the low SEK 220s, placing the September 17, 2026 closing price only a few percent below the 52-week high and roughly 18 to 20 percent above the 52-week low.

At the quoted level and based on the share count used by Yahoo Finance, Essity’s market capitalization currently stands in the large-cap range, underlining its role as a core Nordic consumer staples issuer. Daily trading volume in recent sessions has been in the hundreds of thousands of shares, a liquidity level that typically allows institutional investors to adjust positions around corporate events such as the Edgewell acquisition.

Fundamental backdrop and integration focus

While the Edgewell deal is the immediate catalyst for Essity B stock, investors are also watching how the transaction fits into the group’s most recent financial trajectory from its latest interim report in 2026. Essity’s recent quarterly numbers, published on its investor-relations platform, show mid-single-digit organic sales growth and margin improvement in its tissue and personal care segments in the first half of 2026, providing a base from which to integrate the new feminine care brands. According to Essity, in its latest 2026 interim report available via the company’s investor-relations pages, group net sales increased versus the comparable period in 2025 and operating profit improved as price increases and efficiency measures offset cost pressures.

On this basis, a transaction size of about USD 340 million can be compared against Essity’s half-year operating profit, representing a fraction that is meaningful but not transformational. Historical figures from fiscal year 2024, as presented in Essity’s annual reporting, showed multi-billion SEK net sales with operating margins in the low double digits, meaning that incremental contributions from the Edgewell feminine care assets can potentially lift both the top line and profitability once integration is completed.

For investors, one key question will be how quickly Essity can capture synergies from integrating the Edgewell brands into its existing distribution and production network. Cost savings from procurement and manufacturing, as well as revenue synergies from cross-selling and brand optimization, will determine whether the USD 340 million cash investment yields returns above Essity’s existing margin profile over the next few years.

Analyst lens and risk considerations

Recent analyst commentary on Essity B, as summarized in Nordic equity research over September 2026, has generally characterized the company as a defensive consumer staples holding with stable cash flows and sensitivity to pulp and energy costs. In that context, the Edgewell acquisition is viewed as a strategic move to deepen Essity’s branded portfolio in feminine hygiene, which typically carries relatively resilient demand patterns across economic cycles.

However, analysts also highlight execution risk. Integrating multiple brands such as Playtex, Stayfree, Carefree and o.b. into Essity’s global platform requires marketing investment and potential product repositioning, which can temporarily weigh on margins. In addition, Essity must manage competition from large global consumer-products peers, which also target the same categories.

Another watchpoint is currency and interest-rate dynamics. Because the USD 340 million purchase price is denominated in US dollars, Essity’s effective investment cost in Swedish krona will depend on the SEK/USD exchange rate at the time of payment. Higher financing costs relative to prior years could also influence the acquisition’s net present value, especially if Essity uses debt funding rather than internal cash flow.

Essity B stock price level as of September 17, 2026

Essity B shares are primarily listed on Nasdaq Stockholm under the ticker ESSITY B. As of the close on September 17, 2026, the stock traded at SEK 264.30, up 0.60 SEK or 0.23 percent versus the prior close, with trading recorded at 5:29 p.m. Central European time. At this level, the price stands only a few percent below the recent 52-week high in the low SEK 270s and clearly above the 52-week low in the low SEK 220s, suggesting that the market currently prices in a constructive view of Essity’s portfolio and the Edgewell feminine care acquisition.